Patients with advanced metastatic cancer at the National Cancer Institute have a 10-20% survival rate within six months.

“people that came to the nci to where i was and i suspect to elsewhere in the nci were generally patients who had progressed through all forms of treatment all standard treatments so they had metastatic disease that had failed to respond to any form of treatment so therefore they were at the nci for experimental treatment and at least for the type of cancer we worked on the survival was between 10 and 20 percent meaning 80 to 90 percent of the people we met were going to die very soon within six months typically”